Modern approaches in the problem of epilepsy in the practice of a nurse
- 作者: Gulian S.G.1, Tsetsera D.E.1, Skvortsov V.V.1, Rodionova I.V.1
-
隶属关系:
- Volgograd State Medical University of the Ministry of Health of the Russian Federation
- 期: 卷 26, 编号 6 (2024)
- 页面: 42-45
- 栏目: Profession: theory and practice
- URL: https://journal-vniispk.ru/0025-8342/article/view/267030
- DOI: https://doi.org/10.29296/25879979-2024-06-09
- ID: 267030
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
The main principle of epilepsy treatment is long-term regular intake of antiepileptic drugs (PEP) to reduce the frequency of seizures or their complete reduction in the absence of clinically significant side effects. Timely detection and correction of adverse reactions is an integral part of the treatment of epilepsy.
作者简介
Sergey Gulian
Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: serguliyan@gmail.com
Student
俄罗斯联邦, VolgogradDiana Tsetsera
Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: diana.tsetsera@bk.ru
Student
俄罗斯联邦, VolgogradVsevolod Skvortsov
Volgograd State Medical University of the Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: vskvortsov1@ya.ru
ORCID iD: 0000-0002-2164-3537
Doctor of Medicine, Professor of the Department of Internal Medicine
俄罗斯联邦, VolgogradIrina Rodionova
Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: vskvortsov1@ya.ru
Candidate of Medical Sciences, Associate Professor of the Department of Internal Medicine
俄罗斯联邦, Volgograd参考
- Vera-González A. Pathophysiological Mechanisms Underlying the Etiologies of Seizures and Epilepsy. Exon Publications. 2022; 1–13.
- Chen J. et al. Pathogenesis of seizures and epilepsy after stroke. Acta Epileptologica. 2022; 4: 1–6.
- Scheffer I.E., Berkovic S., Capovilla G. et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58 (4): 512–521.
- Vezzani A., Fujinami R.S., White H.S. et al. Infections, inflammation and epilepsy. Acta Neuropathol. 2016; 131 (2): 211–234.
- Chen, J., Ye, H., Zhang, J. et al. Pathogenesis of seizures and epilepsy after stroke. Acta Epileptologica. 2022; 4 (2).
- Husari K.S., Dubey D. Autoimmune Epilepsy. Neurotherapeutics. 2019; 16 (3): 685–702.
- Toledano M., Pittock S.J. Autoimmune Epilepsy. Semin Neurol. 2015; 35 (3): 245–258.
- Beghi, Ettore. The epidemiology of epilepsy. Neuroepidemiology 2020; 54 (2): 185–191.
- Sarmast S.T., Abdullahi A.M., Jahan N. Current Classification of Seizures and Epilepsies: Scope, Limitations and Recommendations for Future Action. Cureus. 2020; 12 (9): e10549.
- Scheffer I.E., Berkovic S., Capovilla G. et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58 (4): 512–521. doi: 10.1111/epi.13709. Epub 2017 Mar 8.
- Hirtz D., Berg A., Bettis D. et al. Practice parameter: treatment of the child with a first unprovoked seizure report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003; 60: 166–175.
- Hauser W.A. Should people be treated after a first seizure? Arch Neurol. 1986; 43: 1287–1288.
- Pohlmann-Eden B., Beghi E., Camfield C. et al. The first seizure and its management in adults and children. BMJ. 2006; 332: 339.
- Parkerson K.A., Pathmanathan J.S., Milligan T.A. Optimizing antiepileptic treatment. JCOM. 2009; 16 (10).
- St L., Erik K., Rosenfeld W.E. et al. Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol. 2009; 7: 77–82.
- Wheless J.W. A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters. Expert Rev Neurother 2021; 21 (11): 1195–1205.
- Alvarez V., Lee J.W., Drislane F.W. et al. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison. Epilepsia 2015; 56 (8): 1275–1285.
- Trinka E., Kälviäinen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure 2017; 44: 65–73.
- Kapur J., Elm J., Chamberlain J.M. et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. NETT and PECARN Investigators. N Engl J Med 2019; 381 (22): 2103–2113.
- Möddel G., Bunten S., Dobis C. et al. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry 2009; 80 (6): 689–692.
- Chamberlain J.M., Kapur J., Shinnar S. et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet 2020; 395 (10231): 1217–1224.
- Kim H.K., Lee H., Bae E-K. et al. Cardiac effects of rapid intravenous loading of lacosamide in patients with epilepsy. Epilepsy Res 2021; 176: 106710.
- Amengual-Gual M., Sanchez Fernandez I., Wainwright M.S. Novel drugs and early polypharmacotherapy in status epilepticus. Seizure 2019; 68 (3): 79–88.
- Fujikawa D.G. Starting ketamine for neuroprotection earlier than its current use as an anesthetic/antiepileptic drug late in refractory status epilepticus. Epilepsia 2019; 60 (5): 373–380.
补充文件
